Serogroup W Meningitis Outbreak at the Subdistrict Level, Burkina Faso, 2012
- PMID: 26488128
- PMCID: PMC4622241
- DOI: 10.3201/eid2111.150304
Serogroup W Meningitis Outbreak at the Subdistrict Level, Burkina Faso, 2012
Abstract
In 2012, Neisseria meningitidis serogroup W caused a widespread meningitis epidemic in Burkina Faso. We describe the dynamic of the epidemic at the subdistrict level. Disease detection at this scale allows for a timelier response, which is critical in the new epidemiologic landscape created in Africa by the N. meningitidis A conjugate vaccine.
Keywords: Burkina Faso; MenAfriVac; Meningitis Belt; Neisseria meningitides; Sub-Saharan Africa; bacteria; epidemic; immunization; meningococcal conjugate vaccine; meningococcal meningitis; outbreak; policy; serogroup W meningococcal meningitis; vaccine.
Figures


Similar articles
-
Bacterial meningitis epidemiology and return of Neisseria meningitidis serogroup A cases in Burkina Faso in the five years following MenAfriVac mass vaccination campaign.PLoS One. 2017 Nov 2;12(11):e0187466. doi: 10.1371/journal.pone.0187466. eCollection 2017. PLoS One. 2017. PMID: 29095907 Free PMC article.
-
Emergence of serogroup X meningococcal disease in Africa: need for a vaccine.Vaccine. 2013 Jun 12;31(27):2852-61. doi: 10.1016/j.vaccine.2013.04.036. Epub 2013 Apr 24. Vaccine. 2013. PMID: 23623866 Review.
-
Serogroup A meningococcal conjugate (PsA-TT) vaccine coverage and measles vaccine coverage in Burkina Faso--implications for introduction of PsA-TT into the Expanded Programme on Immunization.Vaccine. 2015 Mar 17;33(12):1492-8. doi: 10.1016/j.vaccine.2015.01.043. Epub 2015 Jan 28. Vaccine. 2015. PMID: 25636915 Free PMC article.
-
Serogroup A meningococcal conjugate vaccine coverage after the first national mass immunization campaign-Burkina Faso, 2011.MMWR Morb Mortal Wkly Rep. 2012 Dec 21;61(50):1022-4. MMWR Morb Mortal Wkly Rep. 2012. PMID: 23254256
-
Priorities for research on meningococcal disease and the impact of serogroup A vaccination in the African meningitis belt.Vaccine. 2013 Mar 1;31(11):1453-7. doi: 10.1016/j.vaccine.2012.12.035. Epub 2012 Dec 27. Vaccine. 2013. PMID: 23273967 Free PMC article.
Cited by
-
Meningococcal Disease Outbreaks: A Moving Target and a Case for Routine Preventative Vaccination.Infect Dis Ther. 2021 Dec;10(4):1949-1988. doi: 10.1007/s40121-021-00499-3. Epub 2021 Aug 11. Infect Dis Ther. 2021. PMID: 34379309 Free PMC article. Review.
-
Prevalence and epidemiology of meningococcal carriage in Southern Ethiopia prior to implementation of MenAfriVac, a conjugate vaccine.BMC Infect Dis. 2016 Nov 4;16(1):639. doi: 10.1186/s12879-016-1975-3. BMC Infect Dis. 2016. PMID: 27814682 Free PMC article.
-
Emergence of Neisseria meningitidis Serogroup W, Central African Republic, 2015-2016.Emerg Infect Dis. 2018 Nov;24(11):2080-2083. doi: 10.3201/eid2411.170817. Emerg Infect Dis. 2018. PMID: 30334720 Free PMC article.
-
Nationwide Trends in Bacterial Meningitis before the Introduction of 13-Valent Pneumococcal Conjugate Vaccine-Burkina Faso, 2011-2013.PLoS One. 2016 Nov 10;11(11):e0166384. doi: 10.1371/journal.pone.0166384. eCollection 2016. PLoS One. 2016. PMID: 27832151 Free PMC article.
-
Characterization of strains of Neisseria meningitidis causing meningococcal meningitis in Mozambique, 2014: Implications for vaccination against meningococcal meningitis.PLoS One. 2018 Aug 8;13(8):e0197390. doi: 10.1371/journal.pone.0197390. eCollection 2018. PLoS One. 2018. PMID: 30089105 Free PMC article.
References
-
- World Health Organization. Meningococcal disease in countries of the African meningitis belt, 2012—emerging needs and future perspectives. Wkly Epidemiol Rec. 2013;88:129–36 . - PubMed
-
- World Health Organization. Meningitis outbreak response in sub-Saharan Africa: WHO guideline. 2014. [cited 2015 Jan 22]. http://apps.who.int/iris/bitstream/10665/144727/1/WHO_HSE_PED_CED_14.5_e... - PubMed
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Other Literature Sources